Resectable Pancreatic Duct Adenocarcinoma
2 clinical trials · Condition
◉ Watch Resectable Pancreatic Duct Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma (NCT02959879) | University Hospital, Rouen | 2017-03-01 |
Track Resectable Pancreatic Duct Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.